Cargando…

Reproductive outcomes of female patients with congenital adrenal hyperplasia due to 21-hydroxylase defi ciency

Fertility in women with congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency (21-OHD) appears to be reduced, especially in women with the classic salt-wasting type. Several factors have been suggested to contribute to this subfertility such as androgen excess, adrenal progesterone h...

Descripción completa

Detalles Bibliográficos
Autores principales: Mnif, Mouna Feki, Kamoun, Mahdi, Kacem, Faten Hadj, Mnif, Fatma, Charfi, Nadia, Naceur, Basma Ben, Rekik, Nabila, Abid, Mohamed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3784860/
https://www.ncbi.nlm.nih.gov/pubmed/24083158
http://dx.doi.org/10.4103/2230-8210.117196
Descripción
Sumario:Fertility in women with congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency (21-OHD) appears to be reduced, especially in women with the classic salt-wasting type. Several factors have been suggested to contribute to this subfertility such as androgen excess, adrenal progesterone hypersecretion, consequences of genital reconstructive surgery, secondary polycystic ovaries syndrome, and psychosexual factors. In contrast to this subfertility, pregnancies are commonly normal and uneventful. Adequate glucocorticoid therapy and improvement of surgical and psychological management could contribute to optimize fertility in CAH female patients, even among women with the classic variant. This review provides current information regarding the reproductive outcomes of women with CAH due to 21-OHD and the fertility and pregnancy issues in this population.